Enterprise League logo
AlphaVax Logo

AlphaVax

Research Triangle Park, United States (US) · Health and Medical

Do you work at AlphaVax?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#alphavirus

#vaccine

AlphaVax is a Health and Medical company based in Research Triangle Park, United States (US), with 50-100 employees. AlphaVax's profile is verified on Enterprise League.

Overview

AlphaVax is a US-based biotechnology company specializing in the development of innovative vaccine platforms, headquartered in Research Triangle Park, North Carolina.

We are dedicated to creating next-generation vaccines targeting significant global health challenges, including pandemic influenza and cytomegalovirus (CMV). Our research focuses on leveraging alphavirus vector technology to generate robust and balanced antibody and cellular immune responses, as demonstrated in early human clinical trials.

AlphaVax’s commitment to scientific excellence and a decade of intensive pre-clinical research positions us as a leader in vector-based vaccine development. We collaborate with grant programs and industry partners to advance our pipeline and deliver impactful solutions.

Currently, we are focused on expanding our research and development efforts, with a team of 51-200 professionals.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@alphavax.com

Research Triangle Park, United States (US), 2 Triangle Drive

Company Type

Private Limited Company

Employees

50-100

Categories

Biopharma
Life Science
Biotechnology

Keywords

#alphavirus

#vaccine

Awards

• 2026 OpenSee all

Products

Default Product Image
Alphavaccine Vector Platform
Biotechnology

AlphaVax’s core technology – the alphavirus vector platform – is a proprietary system for delivering genetic material to stimulate targeted immune responses. This platform is designed for rapid vaccine development and offers the potential for broad applicability across various infectious diseases and cancer therapies.

N/A


Services

Default Product Image
Vaccine Development Services
Biotechnology

AlphaVax provides custom vaccine development services to pharmaceutical and biotechnology companies. Leveraging our expertise in vector technology and immunological research, we offer support from preclinical development through early clinical trials.

N/A

Companies teams usually look at after AlphaVax

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.